Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia. Pinkal M. Desai , Janice Brown , Saar Gill , Melham M. Solh , Luke P. Akard , Jack W. Hsu , Celalettin Ustun , Charalambos Andreadis , Olga Frankfurt , James M. Foran , John Lister , Gary J. Schiller , Matthew J. Wieduwilt , John M. Pagel , Patrick J. Stiff , Delong Liu , Irum Khan , Wendy Stock , Suman Kambhampati , Martin S. Tallman , Lawrence Morris , John Edwards , Iskra Pusic , Hagop M. Kantarjian , Richard Mamelok , Alicia Wong , Rodney Van Syoc , Lois Kellerman , Swapna Panuganti , Ramkumar Mandalam , Camille N. Abboud , Farhad Ravandi Journal of Clinical Oncology（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
